Subcutaneous or intravenous opioid administration by patient-controlled analgesia in cancer pain: a systematic literature review
Opioids administered by various routes are a mainstay of tumour-related pain management. Subcutaneous or intravenous patient-controlled analgesia (PCA) with opioids is an appropriate and safe form of treatment for postoperative pain but studies on this form of administration are sparse in the setting of cancer pain despite widespread use.
To evaluate the published studies on opioids administered by subcutaneous and intravenous patient-controlled analgesia for patients with cancer pain.
Articles were identified from the Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 7, 2016), PubMed (Medline; 1975 to 2016) and EMBASE (1974 to 2016). Additional reports were identified from the reference lists of retrieved papers. Studies based on original data with a focus on intravenous or subcutaneous PCA administration of opioids in patients suffering from cancer-related pain were selected. The language was restricted to Dutch, English or German. Predefined information was extracted depending on the topic.
Fifty studies published since 1980 met the inclusion criteria. A wide range of study designs, study quality and research objectives were observed. The studies indicated use of standard or by proxy PCA in the inpatient and outpatient setting were safe and useful while significant adverse effects were rarely observed.
This systematic review of the current evidence suggests PCA can be appropriately used in a wide range of clinical situations.
KeywordsPatient-controlled analgesia Cancer Pain Opioid Review
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.McGrath PJ, Walco GA, Turk DC, Dworkin RH, Brown MT, Davidson K, Eccleston C, Finley AG, Goldschneider K, Haverkos L, Hertz S, Ljungman G, Palermo T, Rappaport BA, Rhodes T, Schechter N, Scott J, Sethna NF, Svensson OK, Stinson J, von Baeyer CL, Walker L, Weisman S, White RE, Zajicek A, Zeltzer L (2008) Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations. J Pain 9(9):771–783PubMedGoogle Scholar
- 2.O’Connor AB, Turk DC, Dworkin RH, Katz NP, Colucci R, Haythornthwaite JA, Klein M, O’Brien C, Posner K, Rappaport BA, Reisfield G, Adams EH, Balster RL, Bigelow GE, Burke LB, Comer SD, Cone E, Cowan P, Denisco RA, Farrar JT, Foltin RW, Haddox JD, Hertz S, Jay GW, Junor R, Kopecky EA, Leiderman DB, McDermott MP, Palmer PP, Raja SN, Rauschkolb C, Rowbotham MC, Sampaio C, Setnik B, Smith SM, Sokolowska M, Stauffer JW, Walsh SL, Zacny JP (2013) Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain 154(11):2324–2334. https://doi.org/10.1016/j.pain.2013.06.035 PubMedGoogle Scholar
- 3.Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrer JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath PA, Quessy S, Rappaport BA, Robinson JP, Royal MA, Lee S, Stauffer JW, Stein W, Tollett J, Witter J (2003) Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 106(337):345Google Scholar
- 8.McNicol ED, Ferguson MC, Hudcova J (2015) Patient controlled opioid analgesia versus non-patient controlled opioid analgesia for postoperative pain. Cochrane Database Syst Rev 2015 6 (Art. No.: CD003348.). doi: https://doi.org/10.1002/14651858.CD003348.pub3
- 16.Bruera E, Michaud M, Brennels C, MacMillan K, MacDonald N (1988) A randomized cross-over trial of patient controlled subcutaneous analgesia versus continuous subcutaneous in patients with cancer pain. Proceedings, annual meeting of the American Society of Clinical Oncology Abs. 1107Google Scholar
- 17.Bruera E, Velasco-Leiva A, Spachynski K, Fainsinger R, Miller MJ, MacEachern T (1993) Use of the Edmonton injector for parenteral opioid management of cancer pain: a study of 100 consecutive patients. J Pain Symptom Manag 8(8):525–528Google Scholar
- 19.Citron ML, Kalra JM, Seltzer VL, Chen S, Hoffman M, Walczak MB (1992) Patient-controlled analgesia for cancer pain: a long-term study of inpatient and outpatient use. Cancer Investig 10(5):335–341Google Scholar
- 20.Dev R, Del Fabbro E, Bruera E (2011) Patient-controlled analgesia in patients with advanced Cancer. Should patients be in control? J Pain Symptom Manage iGoogle Scholar
- 22.Flory JH, Wiesenthal AC, Thaler HT, Koranteng L, Moryl N (2016) Methadone use and the risk of hypoglycemia for inpatients with cancer pain. J Pain Symptom Manag 51(1):79–87. e71Google Scholar
- 25.Sabatowski R, Kasper SM, Radbruch L (2002) Patient-controlled analgesia with intravenous L-methadone in a child with cancer pain refractory to high-dose morphine. J Pain Symptom Manag 23(1):3–5Google Scholar
- 26.Tobias JD, Baker DK (1992) Patient-controlled analgesia with fentanyl in children. Clin Pediatr 31(3):177–179Google Scholar
- 33.Mherekumombe MF, Collins JJ (2015) Patient-controlled analgesia for children at home. J Pain Symptom Manag 49(5):923–927Google Scholar
- 46.Bruera E (1989) The use of subcutaneous patient controlled analgesia. J Pain Symptom Manag 4(2):97–100Google Scholar
- 48.Turk DC, Dworkin RH, McDermott B, Bellamy N, Burke LB, Chandler J, Cleeland CS, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad A, Jay GW, Jermano JA, Katz NP, Manning DC, Martin S, Max MB, McGrath P, McQuay H, Quessy S, Rappaport BA, Revicki D, Rothman M, Stauffer JW, Svensson OK, White RE, Witter J (2008) Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Pain 139:485–493PubMedGoogle Scholar
- 49.Turk DC, Dworkin RH, Burke L, Gershon R, Rothman R, Scott J, Allen RR, Atkinson JH, Chandler J, Cleeland C, Cowan P, Dimitrova R, Dionne R, Farrar JT, Haythornwaite JA, Hertz S, Jadad AR, Jensen MP, Kellstein D, Kerns RD, Manning DC, Martin S, Max MB, McDermott MP, McGrath PA, Moulin DE, Nurmikko T, Quessy S, Raja S, Rappaport BA, Rauschkolb C, Robinson JP, Royal MA, Simon L, Stauffer JW, Stucki G, Tollett J, von Stein T, Wallace MS, Wernicke J, White RE, Williams AC, Witter J, Wyrwich KW (2006) Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain 125:208–215PubMedGoogle Scholar
- 62.Franson HE (2010) Postoperative patient-controlled analgesia in the pediatric population: a literature review. AANA J 78(5)Google Scholar
- 66.Pöder U, Ljungmann G, von Essen L (2010) Parent’s perception of their children’s cancer-related symptoms during treatment: a prospective, longitudinal study. J Pain Symptom Manag 40(5):661–670Google Scholar
- 68.Anghelescu D, Faughnan L, Oakes L, Windsor K, Burgoyne L (2011) F280 the safety of parent (proxy)-controlled analgesia aa a pediatric oncology center. Eur J Pain Supplements 5 (1):147Google Scholar
- 71.Auvil-Novak SE, Novak RD, Smolensky MH, Kavanagh JJ, Kwan JW, Wharton JT (1988) Twenty-four hour variation in self-administration of morphine sulfate (MS) and hydromorphone (H) by post-surgical gynecologic cancer patients. Annu Rev Chronopharm 5:343–346Google Scholar
- 72.Cerchietti LCA, Navigante AH, Körte MW, Cohen AM, Quiroga PN, Villaamil EC, Bonomi MR, Roth BM (2003) Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: a pilot study. Pain 105(1):254–273Google Scholar